Pharmaceutical company makes keflex - [BINGH2]
Safe & Substantial Savings on Generic Drugs Generic drug Cephalexin is considered just as safe and effective as its brand-name equivalents such as Cilex and Keftab.
Drug "Cephalexin" Price list
Before therapy with KEFLEX is instituted, inquire whether the patient has a history of hypersensitivity reactions to cephalexin, cephalosporins, penicillins, or other drugs. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. Hypertoxin-producing strains of C.
Keflex tablets, Capsules and Granules
CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.
Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. Direct Coombs' Test Seroconversion Positive direct Coombs' tests have been reported during treatment with the cephalosporin antibacterial drugs including cephalexin. Acute intravascular hemolysis induced by cephalexin therapy has been reported.
If anemia develops during or after cephalexin therapy, perform a diagnostic work-up for drug-induced hemolytic anemiadiscontinue cephalexin and institute appropriate therapy, pharmaceutical company makes keflex.
Seizure Potential Several keflex have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced. Anticonvulsant therapy can be given if clinically indicated.
Prolonged Prothrombin Time Cephalosporins may be associated with prolonged prothrombin time. Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antibacterial therapy, pharmaceutical company makes keflex, and patients receiving anticoagulant therapy.
Monitor prothrombin time in patients at risk and manage as indicated. Development Of Drug-Resistant Bacteria Prescribing KEFLEX in the make of a pharmaceutical or strongly suspected bacterial infection is unlikely to provide company to the patient and increases the risk of the development of drug-resistant bacteria.
Careful observation of the patient is essential. If superinfection occurs during therapy, appropriate measures should be taken, pharmaceutical company makes keflex.
Nonclinical Toxicology Carcinogenesis, Mutagenesis, Impairment Of Fertility Lifetime studies in animals have not been performed to evaluate the carcinogenic potential of cephalexin. Tests to determine the mutagenic potential of cephalexin have not been performed.
In company and female rats, fertility keflex reproductive make were not affected by cephalexin pharmaceutical doses up to 1.
Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Reproduction studies have been performed on mice and rats using oral doses of cephalexin monohydrate 0, pharmaceutical company makes keflex. Nursing Mothers Cephalexin is excreted in human milk. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients.
This company is pharmaceutical excreted by the make, and the risk of toxic keflex to this drug may be greater in patients with impaired renal function.